Cigna Corporation

267.88+2.75+1.04%Vol 1.63M1Y Perf 11.82%
Jun 27th, 2022 16:00 DELAYED
BID263.21 ASK271.56
Open264.34 Previous Close265.13
Pre-Market- After-Market268.71
 - -  0.83 0.31%
Target Price
295.75 
Analyst Rating
Moderate Buy 1.78
Potential %
10.40 
Finscreener Ranking
★★+     48.26
Insiders Trans % 3/6/12 mo.
-100/-100/-87 
Value Ranking
★★+     49.91
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
★★+     50.21
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-99 
Income Ranking
★★★+     46.66
Price Range Ratio 52W %
93.04 
Earnings Rating
Sell
Market Cap84.99B 
Earnings Date
4th Aug 2022
Alpha0.00 Standard Deviation0.08
Beta0.78 

Today's Price Range

262.31269.16

52W Range

191.74273.58

5 Year PE Ratio Range

8.3029.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
6.23%
1 Month
-1.66%
3 Months
9.94%
6 Months
16.20%
1 Year
11.82%
3 Years
70.03%
5 Years
59.33%
10 Years
507.26%

TickerPriceChg.Chg.%
CI267.882.75001.04
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 20225.136.0117.15
Q04 20214.684.771.92
Q03 20215.235.739.56
Q02 20214.965.245.65
Q01 20214.424.737.01
Q04 20203.663.51-4.10
Q03 20204.254.413.76
Q02 20205.055.8115.05
Earnings Per EndEstimateRevision %Trend
6/2022 QR5.44-7.80Negative
9/2022 QR5.80-3.65Negative
12/2022 FY22.710.89Positive
12/2023 FY25.260.40Positive
Next Report Date4th Aug 2022
Estimated EPS Next Report5.44
Estimates Count9
EPS Growth Next 5 Years %11.10
Volume Overview
Volume1.63M
Shares Outstanding317.27K
Shares Float316.22M
Trades Count33.99K
Dollar Volume434.86M
Avg. Volume1.83M
Avg. Weekly Volume2.05M
Avg. Monthly Volume1.90M
Avg. Quarterly Volume1.56M

Cigna Corporation (NYSE: CI) stock closed at 267.88 per share at the end of the most recent trading day (a 1.04% change compared to the prior day closing price) with a volume of 1.63M shares and market capitalization of 84.99B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 73700 people. Cigna Corporation CEO is David M. Cordani.

The one-year performance of Cigna Corporation stock is 11.82%, while year-to-date (YTD) performance is 16.66%. CI stock has a five-year performance of 59.33%. Its 52-week range is between 191.74 and 273.575, which gives CI stock a 52-week price range ratio of 93.04%

Cigna Corporation currently has a PE ratio of 16.40, a price-to-book (PB) ratio of 1.83, a price-to-sale (PS) ratio of 0.48, a price to cashflow ratio of 10.90, a PEG ratio of 2.32, a ROA of 3.64%, a ROC of -% and a ROE of 11.77%. The company’s profit margin is 3.07%, its EBITDA margin is -%, and its revenue ttm is $176.98 Billion , which makes it $557.80 revenue per share.

Of the last four earnings reports from Cigna Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.44 for the next earnings report. Cigna Corporation’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Cigna Corporation is Moderate Buy (1.78), with a target price of $295.75, which is +10.40% compared to the current price. The earnings rating for Cigna Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cigna Corporation has a dividend yield of 1.67% with a dividend per share of $4.48 and a payout ratio of 4.00%.

Cigna Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 13.33, ATR14 : 7.59, CCI20 : 51.21, Chaikin Money Flow : 0.06, MACD : -0.81, Money Flow Index : 68.16, ROC : 1.09, RSI : 58.24, STOCH (14,3) : 97.39, STOCH RSI : 1.00, UO : 65.44, Williams %R : -2.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cigna Corporation in the last 12-months were: David M. Cordani (Option Excercise at a value of $19 269 211), David M. Cordani (Sold 146 215 shares of value $38 581 253 ), Donna F. Zarcone (Buy at a value of $210 741), Elder Granger (Option Excercise at a value of $637 062), Elder Granger (Sold 4 844 shares of value $1 148 318 ), Eric Palmer (Option Excercise at a value of $621 705), Eric Palmer (Sold 8 126 shares of value $2 031 500 ), Everett Neville (Option Excercise at a value of $67 836), Everett Neville (Sold 11 506 shares of value $2 667 217 ), Jason D. Sadler (Sold 5 000 shares of value $1 250 000 ), Nicole S. Jones (Option Excercise at a value of $2 832 013), Nicole S. Jones (Sold 26 196 shares of value $6 815 696 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (61.11 %)
11 (68.75 %)
11 (61.11 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (38.89 %)
4 (25.00 %)
6 (33.33 %)
Moderate Sell
0 (0.00 %)
1 (6.25 %)
1 (5.56 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.78
Moderate Buy
1.69
Moderate Buy
1.83

Cigna Corporation

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

CEO: David M. Cordani

Telephone: +1 860 226-6000

Address: 900 Cottage Grove Road, Bloomfield 06002, CT, US

Number of employees: 73 700

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

TipRanks News for CI

Mon, 06 Jun 2022 12:45 GMT Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Legend Biotech (LEGN)

- TipRanks. All rights reserved.

Mon, 09 May 2022 13:32 GMT Cigna Exceeds Q1 Expectations & Issues Upbeat 2022 Outlook

- TipRanks. All rights reserved.

Wed, 20 Apr 2022 12:36 GMT Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Johnson & Johnson (JNJ)

- TipRanks. All rights reserved.

Fri, 25 Mar 2022 16:52 GMT Why Cigna Stock Could Rise Quickly

- TipRanks. All rights reserved.

Fri, 11 Feb 2022 12:25 GMT Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Cigna (CI) and SCYNEXIS (SCYX)

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 15:16 GMT Cigna (CI) Receives a Buy from Mizuho Securities

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 13:38 GMT Cigna (CI) Receives a Hold from Leerink Partners

- TipRanks. All rights reserved.

Fri, 04 Feb 2022 13:15 GMT Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Biogen (BIIB)

- TipRanks. All rights reserved.

Fri, 04 Feb 2022 12:55 GMT Analysts Offer Insights on Healthcare Companies: Cigna (CI) and BioNano Genomics (BNGO)

- TipRanks. All rights reserved.

News

Stocktwits